Modulation of control mechanisms of dopamine-induced apoptosis - A future approach to the treatment of Parkinson's disease?

Journal of Neural Transmission, Supplement

Volumn , Issue 49, 1997, Pages 195-202

  Ziv, I ^a   Offen, D ^a   Barzilai, A ^b   Haviv, R ^b   Stein, R ^b   Zilkha Falb, R ^b   Shirvan, A ^a   Melamed, E ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NORADRENALIN; PROTEIN BCL 2; SEROTONIN; ANTIPARKINSON AGENT;

APOPTOSIS; HUMAN; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; ANIMAL; CORPUS STRIATUM; DRUG EFFECT; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIPARKINSON AGENTS; APOPTOSIS; CORPUS STRIATUM; DOPAMINE; HUMANS; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; RATS; SUBSTANTIA NIGRA;

EID: 0030612211     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6844-8_20     Document Type: Review

References (21)

1. Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, Javoy-Agid F (1990) The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role? Adv Neurol 53: 83-100
2. Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW (1989) Cloning, structure and expression of the mitochondrial cytochrome p-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 264: 8222-8229
3. Barinaga M (1993) Death gives birth to the nervous system. But how? Science 259: 762-763
4. Boise LH, Gonzalez-Garcia MZ, Thompson CB, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
5. Boobis AR, Fawthrop DJ, Davies DS (1989) Mechanisms of cell death. Trends Pharmacol Sci 10: 275-280
6. Eastman A (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2: 275-280
7. Garcia I, Martinou I, Tsujimoto Y, Martinou JC (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258: 302-30
8. Graham DG, Tiffany SM, Bell WR, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward c1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653
9. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991) Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965
10. Johnson G (1971) Quantitation of fluorescence of biogenic monoamines. Prog Hystochem Cytochem 2: 299-344
11. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentino JS, Örd T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274-1277
12. Martin DP, Schmidt RE, Distefano PS, Lowry OH, Carter JG, Johnson EM Jr (1988) Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829-844
13. Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminer-gic neurons in culture. J Neurosci Res 26: 428-435
14. Moldeus P, Nordenskjold M, Bolcsfoldi G, Eiche A, Haglund U, Lambert B (1983) Genetic toxicity of dopamine. Mut Res 124: 9-24
15. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444
16. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death: Cell 74: 609-619
17. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6
18. Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cyto 68: 251-306
19. Wick MM (1978) Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol 71: 163-164
20. Wick MM (1989) Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. J Invest Dermatol 92: 329S-331S
21. Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett 170: 136-140